title: [How the drug allergy risk in the intensive care software is considered? About a comparative study].
abstract: The aim of this study was to evaluate the way the drug allergy risk was considered in five intensive care software available for the French market. It is an observational study conducted by a survey with the five firms asked during the 26th International Symposium on Intensive Care and Emergency Medicine in Brussels (March 2006). The drug allergic risk is documented to various degrees among the software selections. However, no software proposes an alternative or blocking of the prescription in case of allergy to a drug.
authors: Service d'anesthésie réanimation, HIA Percy, 92140 Clamart, France.
authors: P
authors: P
authors: Pasquier
authors: J-P
authors: JP
authors: Perez
authors: P
authors: P
authors: Clapson
authors: B
authors: B
authors: Debien
authors: A
authors: A
authors: Vichard
authors: B
authors: B
authors: Lenoir
mesh_terms: D001530:Belgium; D003226:Congresses as Topic; D003422:Critical Care / Q000592:standards*; D004342:Drug Hypersensitivity / Q000175:diagnosis* / Q000517:prevention & control; D004635:Emergency Medicine / Q000592:standards; D005602:France; D006306:Health Surveys; D006801:Humans; D007362:Intensive Care Units / Q000592:standards; D012984:Software